Zimmer Biomet Holdings Q1 2026 Earnings Call Summary
Zimmer Biomet Holdings, Inc. reported Q1 2026 results showing strong technology sales growth and momentum from new products, though U.S. Knee growth was impacted by brand rationalization. The company raised adjusted EPS guidance and outlined a strategic roadmap for future product launches and sales force transformation.
Tickers: $ZBH
Topics: Channel Transformation Product Launches Q1 2026 Earnings Revenue Growth Strategic Execution Zimmer Biomet